- 3-12 months depending on stage
- 2-3 weeks after surgery, immunotherapy ongoing for 1-2 years
- 81%
China versus the U.S.
- China clinical rate
- $10,000 – $50,000
- $30,000
- United States
- $60,000 – $250,000
- $155,000
- You save
- ~81%
- $125,000 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Melanoma treatment in China utilizes wide local excision with sentinel lymph node biopsy for early stages, and immunotherapy (PD-1 inhibitors like toripalimab and sintilimab) combined with targeted therapy (BRAF/MEK inhibitors) for advanced disease. Chinese dermatologic oncology centers have developed expertise in acral and mucosal melanoma subtypes that are more prevalent in Asian populations. Domestically produced checkpoint inhibitors offer effective treatment at substantially lower costs.
Step by step.
Biopsy & Molecular Profiling
Excisional biopsy with BRAF, NRAS, and c-KIT mutation testing to guide treatment selection
Wide Excision & SLNB
Surgical removal with adequate margins and sentinel lymph node biopsy for staging
Systemic Therapy
Adjuvant immunotherapy (anti-PD-1) for stage III or targeted therapy for BRAF-mutant disease
Surveillance Program
Regular imaging, blood tests, and skin examinations to detect recurrence early
- Access to affordable domestically-produced PD-1 inhibitors
- Expertise in Asian-prevalent melanoma subtypes (acral/mucosal)
- Comprehensive molecular profiling for targeted therapy
- Lower overall treatment costs with equivalent outcomes
- Immune-related adverse events from checkpoint inhibitors
- Risk of local recurrence or distant metastasis
- Targeted therapy resistance developing over time
- Psychological impact of long-term surveillance
Ask the AI for hospitals that handle melanoma treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.